Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Certain NK cell changes in blood may indicate alopecia areata progression.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Exosomes from certain cells can improve hair regrowth by changing the immune response.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Leukocyte recruitment is complex but crucial for resolving inflammation and developing effective therapies.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Lymphocytes, a type of immune cell, are crucial for wound healing as they help remodel damaged areas and reduce inflammation.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Hair follicles regulate immune cells in the skin, and disrupting certain pathways can lead to skin issues and infections.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Abnormal ECM and immune cell interactions can cause skin diseases.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Targeting CD169+ skin macrophages may help treat psoriasis.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.